Reagentia en instrumenten voor immunologie, celbiologie en moleculaire biologie.
 
> Obinutuzumab [949142-50-1]

Obinutuzumab [949142-50-1]

Afdrukken Afdrukken
Log in alstublieft

Referentie T9924-1mg

Formaat : 1mg

Merk : TargetMol

Neem contact op met een lokale distributeur :


Telefoonnummer : +1 850 650 7790

Obinutuzumab

Obinutuzumab
Contact us for more batch information
Concentration:25.0 mg/mL
Purity:98.00%
Resource Download
COA

Obinutuzumab

Catalog No. T9924Cas No. 949142-50-1
Obinutuzumab (Obinutuzumab/afutuzumab) GA101) is a glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack Size
1 mgIn Stock
5 mgIn Stock

Product Introduction

Bioactivity
Description
Obinutuzumab (Obinutuzumab/afutuzumab) GA101) is a glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma.
AliasObinutuzumab/afutuzumab
Chemical Properties
Molecular Weight150 kDa
Cas No.949142-50-1
Storage & Solubility Information
Storagestore at low temperature store at -20°C

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

InhibitorGA 101Anti-Human CD20 type II, Humanized AntibodyinhibitGA101GA-101Obinutuzumab

Misschien heeft u ook interesse in de volgende producten:



Referentie
Beschrijving
Cond.
Price Bef. VAT
HY-P9910-1mg
Obinutuzumab [949142-50-1]
 1mg